Search

Search

Log in or registerMenuClose

Search

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

Rankings
Firms & Lawyers
In-House
- In-House Content
- GC Powerlist
Knowledge Centre
- About us

Comparative Guides
Events
Legal 500 TV

About us

Legal 500
FAQs
Marketing
Careers
Trust Centre
Contact us

Deutschland DE
Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

Legal 500 Trust Centre
Contact Us

Market Intelligence
Search

482 results found

Use advanced search filters to refine your search

Search

2 filters applied

Advanced search filters

Topics

Search for topics

Countries

Search for countries

Contributor

Search to show contributors

Start typing to add contributors

Content type

Any
Article
Podcast
Video

Sort by

Article
China's State Council Announces Reform On The Drug And Device Approval System
China will launch new reforms of its current review and approval system for drugs and medical devices, announced by China's State Council, in its August 18, 2015, circular ...
ChinaFood, Drugs, Healthcare, Life Sciences
Ropes & Gray LLP
Article
China's State Council Announces Reform On The Drug And Device Approval System
China will launch new reforms of its current review and approval system for drugs and medical devices, announced by China's State Council, in its August 18, 2015, circular Opinions Concerning the Reform of the Review and Approval System for Drugs and Medical Devices Issued by the State Council (the "Opinions", Guo Fa Notice [2015] No.44).
ChinaFood, Drugs, Healthcare, Life Sciences

Ropes & Gray LLP

【华源原创】从专利视角，聊一聊心脏支架降价背后的真相

前不久"心脏支架集中带量采购，费用从1万元降低到700元"以及"首批700多元心脏支架在北京、天津、河北等多个省市正式落地实施"的消息被各大新闻&

ChinaIntellectual Property

東陽光薬、中国特許金賞を受賞　国際特許出願で世界展開を加速

広東東陽光薬業公司（以下、東陽光薬）が第25回中国...

ChinaIntellectual Property

A new wave of regulatory enforcement actions in China impact the food and pharmaceutical industries

China is currently witnessing an extended government campaign to tackle corruption on an unprecedented scale.

ChinaFood, Drugs, Healthcare, Life Sciences

DLA Piper Australia

China Announces A Detailed Pilot Plan For The Marketing Authorization Holder System For Drugs In Selected Regions

China's State Council announced on May 26, 2016, a detailed pilot plan for the Marketing Authorization Holder System ("MAH") for drugs in 10 provinces in China.

ChinaFood, Drugs, Healthcare, Life Sciences

Ropes & Gray LLP

China CFDA Finalizes Infant Formula Registration Rules

On 6 June 2016, China Food and Drug Administration ("CFDA") published Administrative Measures on Product Formula Registration of Infant Formula Milk Powder ("Measures") for purpose...

ChinaFood, Drugs, Healthcare, Life Sciences

MyLink Law Office

China Cracking Down On Pharmaceutical Corruption

On December 25, 2013, the National Health and Family Planning Commission of China issued the amended "Provisions Regarding the Establishment of Commercial Bribery Blacklist in the Pharmaceutical Purchase and Sales Industries", which came into effect on March 1, 2014.

ChinaFood, Drugs, Healthcare, Life Sciences

Chinese FDA Soliciting Public Comments On Rules For Re-Packaging Of IVDs

The State Food and Drug Administration ("SFDA") in China published a draft of the Tentative Measures for the Administration of the Registration of Re-Packaging In-Vitro Devices (IVDs) ("Draft Measures") on November 2 for public comments through November 20.

ChinaFood, Drugs, Healthcare, Life Sciences

Ropes & Gray LLP

Plant-Based Foods: Exciting Technology, But Don't Overlook The Regulatory Considerations

As China starts to emerge and recover from COVID-19, more and more food brands are entering into the plant-based food space.

ChinaFood, Drugs, Healthcare, Life Sciences

Keller & Heckman

SFDA Bulletins

On 22 January 2013, the PRC’s National Development and Reform Commission issued guidance on accelerating consolidation within the pharmaceutical sector.

ChinaFood, Drugs, Healthcare, Life Sciences

China Update

SIPO received 825,000 invention patent applications in 2013 which increased 26.3% year-on-year.

ChinaIntellectual Property

CN Drug Patent Registration System (Orange Book) Opened For Testing

This was opened on 18 May 2021 (http://www.cde.org.cn/news.do?method=largeInfo&id=464a59511b09ddfc). The test is to be ended on 31 May 2021....

ChinaIntellectual Property

First Ever Preliminary Injunction Issued By Chinese Court In Pharmaceutical Patent Case

The Beijing IP Court has issued a preliminary injunction against a patent infringer in a pharmaceutical case earlier this year.

ChinaIntellectual Property

China Sinda Intellectual Property Ltd

Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued

This case is the first drug patent linkage lawsuit in China since the newly amended Patent Law came into force.

ChinaIntellectual Property

NMPAとCNIPAは医薬品特許紛争の早期解決メカニズム創設に

医薬品特許権者の合法的権益を保護し、新薬の研究の奨励及びハイレベルのジェネリック薬の発展を促進するため、国家薬品監督管理局（NMPA

ChinaIntellectual Property

중국 베이징 지식재산권법원, 최초의 의약품 허가특허연계제도 소송 판결 선고

2022년 4월 15일, 중국 베이징 지식재산권법원은 원고 중외제약주식회사가 피고...

ChinaIntellectual Property

Overseas M&A Strategies In The Pharma Industry

The motivations and strategies for Chinese enterprises' overseas acquisitions vary from industry to industry.

ChinaCorporate/Commercial Law

Analysis of the revisions in the Drug Administration Law of PRC

The article discusses three highlights of the newly amended Drug Administration Law relating to registration and price.

ChinaFood, Drugs, Healthcare, Life Sciences

King & Wood Mallesons

China FDA Solicits Comments On Resolving The Backlog Of Drug Applications

The China Food and Drug Administration ("CFDA") recently published a draft circular to address the backlog of drug applications.

ChinaFood, Drugs, Healthcare, Life Sciences

Ropes & Gray LLP

Showing 121–140 of 482 results

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics